Integrate
The INTEGRATE project aims at building and maintaining a large, curated collection of virological and clinical data to increase scientific knowledge on resistance to integrase strand transfer inhibitors (InSTI) and on the most appropriate use of this class of antiretroviral agents. The project takes advantage of the EuResist Network structure and expertise to manage the […]
AVITHRAPID
The fight against global health threats from viral diseases takes a big step forward with AVITHRAPID “Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases”. This ambitious project aims to create a pipeline of promising antiviral drugs built on existing small molecules with proven effectiveness against various viruses. These molecules will be rapidly developed into new […]
VIROMARKERS
The overall aim of VIROMARKERS is to define virus related biomarkers to improve management of chronic diseases, including biomarkers of response to antiviral treatment of persistent viral infections and virome features as indicators of disease progression in immunosuppressed people. Validation or demonstration of the technologies required to measure the candidate biomarkers is an integral part […]
EuCARE
Coordinated by Euresist Network, 25 primary universities, hospitals and ICT research centres are collaborating to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. This is the EuCARE Project! How do SARS-COV-2 variants, coupled with other factors, influence the clinical course of COVID-19? Is there any vaccine or test escape related […]
EuResist Mentor School
EuResist Network has launched an educational activity finalised to train young physicians and biologists in dealing with structured data (databases). The overall objectives of the initiative are to nurture a generation of scientists able to bridge the gap among medical/biological sciences and IT data management/statistics and to exploit at best the potential of structured collections […]
New publication “Data privacy, data property and data sharing” in post-pandemic research
The book on “Data privacy, data property and data sharing” was published by Routledge on 16 December 2025.This publication addresses the controversial issues surrounding data sharing, including data protection, ownership and reuse, and the related ethical considerations, answering the “cahier de doleance” arising from biomedical research with data. Edited by Mariavittoria Catanzariti, Francesca Incardona, Giorgio […]
EuResist Network Joins Key Bilateral Event in China
EuResist Network has been selected to participate in the XIV China-Italy Science, Technology, and Innovation Week. This prestigious event for scientific and technological cooperation, is organized under the auspices of the Italian Ministry of University and Research and the Chinese Ministry of Science and Technology.The Week, scheduled from November 13 to November 20, 2025, in […]
CARE4ART resutls presented at the 20th European AIDS Conference
EuResist Network GEIE was at the 20th European AIDS Conference for insights on INSTI resistance in people with HIV-1A6!A poster detailing results from the @EuResist CARE4ART international study is now at the 20th European AIDS Conference in Paris (October 15-18, 2025). Dr. Maarten van de Klundert is presenting: “Analysis of viral load and INSTI resistance […]
EuResist Celebrates EU Day at the AREVIR meeting with a focus on Collaborative EU Project
Today, May 9th, marks EU Day, a celebration of European cooperation and unity. Here at EuResist, we’re proud to embody this spirit through our active participation in impactful EU-funded projects. To mark the occasion, Francesca Incardona attended the AREVIR meeting in Cologne by sharing insights into the three EU projects that EuResist is involved in. […]
Rome Hosts Successful Launch of VIROMARKERS Project
The VIROMARKERS project, started on February 1, 2025, celebrated its official launch with a dynamic kickoff meeting in Rome on April 3rd and 4th, 2025. The event fostered lively scientific discussions within a friendly and collaborative setting, signaling an exciting start for the consortium. Driven by a shared goal, VIROMARKERS will focus on developing groundbreaking […]